A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2 '-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer

Title: A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2 '-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer
Author(s): Glasspool, RM
Brown, R
Gore, ME
Rustin, GJS
McNeish, IA
Wilson, RH
Pledge, S
Paul, J
Mackean, M
Hall, GD
Gabra, H
Halford, SER
Walker, J
Appleton, K
Ullah, R
Kaye, S
Item Type: Journal Article
Publication Date: 18-Mar-2014
Date of Acceptance: 9-Feb-2014
URI: http://hdl.handle.net/10044/1/25705
DOI: https://dx.doi.org/10.1038/bjc.2014.116
ISSN: 1532-1827
Publisher: Cancer Research UK
Start Page: 1923
End Page: 1929
Journal / Book Title: British Journal of Cancer
Volume: 110
Issue: 8
Copyright Statement: © 2014 Cancer Research UK.This work is published under the standard license to publish agreement. 12 months after publication the work will become freely available and the license terms will switch to a Creative Commons AttributionNonCommercial-Share Alike 3.0 Unported License.
Publication Status: Published
Appears in Collections:Division of Surgery
Division of Cancer
Faculty of Medicine



Items in Spiral are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons